We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Corvus Pharmaceuticals
CRVS
$1.09B
| $370K | ﹤0.01% |
373,400
-43,800
| -10% | -$53.7K |
|
2052
Tilray
TLRY
$498M
| $369K | ﹤0.01% |
+11,830
| New | +$559K |
|
2053
LiveRamp
RAMP
$2.3B
| $367K | ﹤0.01% |
+14,200
| New | +$421K |
|
|
BRDG
2054
DELISTED
Bridge Investment Group
BRDG
| $366K | ﹤0.01% |
25,200
+5,400
| +27% | +$96K |
|
2055
CorMedix
CRMD
$596M
| $366K | ﹤0.01% |
91,100
+42,200
| +86% | +$157K |
|
2056
Everest Group
EG
$15.4B
| $364K | ﹤0.01% |
1,300
-6,400
| -83% | -$1.81M |
|
2057
MongoDB
MDB
$24.9B
| $363K | ﹤0.01% |
1,400
-8,300
| -86% | -$2.59M |
|
2058
Bloomin' Brands
BLMN
$731M
| $362K | ﹤0.01% |
21,800
+7,500
| +52% | +$152K |
|
2059
Liquidity Services
LQDT
$1.21B
| $362K | ﹤0.01% |
26,900
-1,700
| -6% | -$25K |
|
|
LX
2060
LexinFintech Holdings
LX
$241M
| $362K | ﹤0.01% |
162,487
+141,300
| +667% | +$327K |
|
|
SPTN
2061
DELISTED
SpartanNash
SPTN
| $362K | ﹤0.01% |
12,000
-8,700
| -42% | -$288K |
|
2062
TE Connectivity
TEL
$60.2B
| $362K | ﹤0.01% |
+3,200
| New | +$396K |
|
|
JOYY
2063
JOYY Inc
JOYY
$3.77B
| $361K | ﹤0.01% |
12,100
-4,000
| -25% | -$147K |
|
2064
Outlook Therapeutics
OTLK
$198M
| $357K | ﹤0.01% |
17,505
-9,560
| -35% | -$275K |
|
2065
Bank OZK
OZK
$5.5B
| $357K | ﹤0.01% |
9,500
-15,200
| -62% | -$600K |
|
2066
Rigel Pharmaceuticals
RIGL
$692M
| $357K | ﹤0.01% |
31,559
+26,380
| +509% | +$530K |
|
2067
Goodyear
GT
$2.04B
| $355K | ﹤0.01% |
33,124
-118,800
| -78% | -$1.49M |
|
2068
Honda
HMC
$37.8B
| $355K | ﹤0.01% |
+14,700
| New | +$376K |
|
2069
BancFirst
BANF
$3.89B
| $354K | ﹤0.01% |
3,700
-15,400
| -81% | -$1.34M |
|
|
FSR
2070
DELISTED
Fisker Inc.
FSR
| $351K | ﹤0.01% |
41,000
+27,700
| +208% | +$287K |
|
2071
Caesarstone
CSTE
$75.7M
| $349K | ﹤0.01% |
38,200
+12,200
| +47% | +$117K |
|
2072
First American
FAF
$7.79B
| $349K | ﹤0.01% |
6,600
+1,400
| +27% | +$81.5K |
|
2073
Stem
STEM
$50M
| $347K | ﹤0.01% |
2,425
-15,920
| -87% | -$2.65M |
|
2074
Moelis & Co
MC
$5.04B
| $346K | ﹤0.01% |
8,800
-7,000
| -44% | -$305K |
|
2075
Red River Bancshares
RRBI
$657M
| $346K | ﹤0.01% |
6,400
-1,800
| -22% | -$95.6K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.